iShares U.S. Pharmaceuticals ETF Rating $66.16 +1.29 (+1.99%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.69Holdings in IHE have an aggregate rating of Moderate Buy based on 328 analyst ratings issued in the past year covering 37 companies (99.6% of the portfolio).IHE Aggregate Price Target$66.160.12% UpsideHigh Prediction$66.16Average Prediction$66.16Low Prediction$66.16Holdings in IHE have an aggregate price target of $66.16 and a range of $66.16 to $66.16 covering 37 companies (99.6% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings24.14%JNJJohnson & Johnson$154.89-0.3%4.8005 of 5 stars2.56$171.82 10.9%18Positive News23.05%LLYEli Lilly and Company$861.11+3.8%4.8476 of 5 stars2.89$1,017.00 18.1%19Upcoming EarningsAnalyst ForecastAnalyst Revision4.86%RPRXRoyalty Pharma$32.03+1.1%4.6511 of 5 stars3.00$42.50 32.7%5Dividend AnnouncementNews CoveragePositive News4.82%ZTSZoetis$152.52+1.1%4.6041 of 5 stars3.08$214.40 40.6%12Ex-DividendAnalyst RevisionPositive News4.74%BMYBristol-Myers Squibb$48.66+0.3%4.7587 of 5 stars2.35$58.00 19.2%20Earnings ReportAnalyst ForecastAnalyst Revision4.58%PFEPfizer$22.80+1.8%4.9993 of 5 stars2.53$29.57 29.7%17Upcoming EarningsDividend AnnouncementAnalyst ForecastAnalyst Revision4.48%MRKMerck & Co., Inc.$79.93+1.5%5 of 5 stars2.59$111.13 39.0%22Earnings ReportAnalyst ForecastAnalyst RevisionPositive News4.23%VTRSViatris$8.04+2.9%2.99 of 5 stars1.75$10.50 30.6%43.27%CORTCorcept Therapeutics$71.79+3.6%4.4867 of 5 stars3.00$143.25 99.5%5Upcoming EarningsPositive NewsHigh Trading Volume3.14%JAZZJazz Pharmaceuticals$108.98+4.6%4.8955 of 5 stars2.93$187.71 72.2%14Upcoming EarningsNews CoveragePositive News2.13%ELANElanco Animal Health$9.45+2.8%3.975 of 5 stars2.43$14.67 55.2%7Analyst Revision1.94%PBHPrestige Consumer Healthcare$79.47-0.4%4.1101 of 5 stars2.50$93.33 17.4%6Analyst RevisionPositive News1.90%AXSMAxsome Therapeutics$105.41+1.1%4.5488 of 5 stars3.00$169.80 61.1%161.69%PRGOPerrigo$24.87+0.5%4.8543 of 5 stars2.25$33.00 32.7%4Positive News1.59%OGNOrganon & Co.$12.12+5.4%4.8663 of 5 stars2.43$20.60 70.0%7Upcoming EarningsPositive NewsHigh Trading Volume0.89%LGNDLigand Pharmaceuticals$108.55+2.6%4.3368 of 5 stars3.00$146.43 34.9%7News Coverage0.85%SUPNSupernus Pharmaceuticals$31.35+1.7%3.0734 of 5 stars2.33$36.00 14.8%3News Coverage0.77%TARSTarsus Pharmaceuticals$49.97-0.1%2.3188 of 5 stars3.00$63.67 27.4%7News CoveragePositive News0.53%HRMYHarmony Biosciences$29.43+1.8%4.6183 of 5 stars3.00$53.33 81.2%9Upcoming EarningsShort Interest ↓Positive News0.53%ANIPANI Pharmaceuticals$69.64+1.9%4.1342 of 5 stars3.00$80.13 15.1%9Analyst ForecastNews CoveragePositive News0.52%AMRXAmneal Pharmaceuticals$7.42+1.6%3.0542 of 5 stars3.00$10.80 45.6%5Positive NewsGap Up0.50%PCRXPacira BioSciences$26.00+3.2%2.0279 of 5 stars2.33$26.67 2.6%9Positive NewsGap Up0.47%AMPHAmphastar Pharmaceuticals$24.07+2.2%4.3081 of 5 stars2.00$43.50 80.7%30.46%INVAInnoviva$18.38+0.1%4.1741 of 5 stars3.00$55.00 199.2%2Analyst DowngradePositive News0.43%COLLCollegium Pharmaceutical$26.78+3.0%4.0932 of 5 stars2.80$43.60 62.8%50.38%OCULOcular Therapeutix$7.90+0.6%3.4454 of 5 stars2.89$16.38 107.3%90.37%EWTXEdgewise Therapeutics$15.40+3.8%2.3312 of 5 stars2.75$40.13 160.6%8Analyst ForecastGap Up0.34%HROWHarrow$25.07+5.2%2.4854 of 5 stars3.00$60.50 141.3%4Positive News0.33%WVEWave Life Sciences$6.794.3263 of 5 stars3.00$22.18 226.7%11Short Interest ↑Positive News0.29%LQDALiquidia$14.03+3.5%2.6822 of 5 stars3.11$26.63 89.8%9News CoveragePositive News0.27%ELVNEnliven Therapeutics$18.33+3.2%1.9745 of 5 stars3.25$40.33 120.0%4News Coverage0.25%EOLSEvolus$11.55+2.8%3.606 of 5 stars3.00$23.75 105.6%50.20%NUVBNuvation Bio$2.12+1.9%3.1906 of 5 stars3.20$7.83 269.5%5Analyst ForecastPositive News0.20%ARVNArvinas$9.14+0.8%3.29 of 5 stars2.69$34.33 275.6%160.19%OMEROmeros$7.30+4.7%3.346 of 5 stars2.80$22.50 208.2%50.17%MNMDMind Medicine (MindMed)$6.43+5.2%2.3634 of 5 stars3.23$25.11 290.5%13News CoveragePositive News0.14%TBPHTheravance Biopharma$9.54+1.0%1.0997 of 5 stars2.25$11.33 18.8%4News Coverage This page (NYSEARCA:IHE) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IHE Stock Free IHE Stock Alerts